UnitedHealth Fell From $620 to $235. Our Score Still Says 98.
UNH scores 98 right now — our ceiling, Strong Buy. That's the same headline number AAPL carried in the piece we published a few hours ago. The chart underneath it tells a completely different story, and the difference is worth walking through, because it's not the "score cheap, chart expensive" conflict we just wrote about. It's something more sobering.
What the score sees
UNH closed Friday, August 14, at $401.73. It's down 4.7% over the past 20 sessions, price now sitting 1.23 ATR below its own 20-day average, RSI at 41. That's the pullback the score is reacting to, and on its own terms it's unremarkable — the same shape of setup that shows up on the board most weeks, for most names. Regime still reads "trend": price remains above a rising 200-day average, so this is a dip inside an uptrend, not a broken chart, by the model's own read.
What the chart sees
Widen out to the weekly chart and a much bigger structure appears. UNH peaked near $620 — call it a multi-year high — and then fell to roughly $235. That's a decline of well over half the stock's value, visible directly in the price action, not something we're asserting from memory. We're not going to guess at why; the chart shows the size of the move, not the cause, and inventing a cause we can't verify would be worse than saying nothing.
What matters for this piece is what happened next: UNH has spent months recovering, and the LuxAlgo Smart Money Concepts overlay marks current price as sitting at Equilibrium — not on the old, pre-crash range, but on the smaller range that's actually formed since the bottom. Roughly $385 to $415. Our own $401.73 close sits almost exactly in the middle of it.
The part that isn't really a conflict
With AAPL, the score and the chart disagreed about the same reference frame — score said cheap on the 20-day, chart said still expensive on the multi-year range. Here, the chart's own read doesn't say UNH is expensive. It says fair value, on the only range that's currently relevant. The old $620 high isn't part of the argument anymore; the chart isn't claiming this stock is due to reclaim it, and neither are we.
So the real question isn't "is the score wrong." It's narrower: is a 4.7% dip inside an already-fair-value range meaningfully buyable, or is it just the normal texture of a stock sitting at equilibrium — noise with no particular edge either way? The score says buyable. The chart, read plainly, is closer to neutral. That's a genuinely different disagreement than "premium versus discount," and it deserves a different name: not conflict, agreement with a catch.
The number we can actually check
Our own archived 52-week low for UNH is $259.02. The chart's crash-bottom tag, read visually off a decade-plus-wide weekly chart, sits closer to $235. Those aren't the same number, and we're not going to pretend they are. A pixel read of a low set that far back on a chart this compressed isn't precise, and the honest version of this piece says so instead of rounding the gap away. Contrast that with the AAPL read published the same day, where the chart's swing high matched our archived 52-week high almost exactly — that was a real, clean cross-check. This one isn't as clean, and the difference is worth noting rather than smoothing over.
What we're actually recording
A dated, falsifiable claim, same as every chart read we publish: if price stays roughly inside the $385–$445 range the chart shows forming since the crash, that's closer to the chart's neutral read holding up. If price gains meaningfully from here without drifting back toward the $235 low, that's the score's buy signal earning its keep. We'll check it at 5, 20, and 60 sessions, same as the QQQM read from three weeks ago and the AAPL read from this morning, and print whatever actually happened.
Scores in this piece come from the ZonedInOut model. How the score works →
Frequently asked
Can a stock be both "cheap" by one measure and "fairly valued" by another at the same time?
What does it mean when a stock is trading at "Equilibrium" after a major decline?
Does a stock need to return to its old all-time high to be considered a good investment?
Get the Sunday Brief
One email a week, before the open: what the board did, which calls worked, which didn't, and what changed. Free. No spam, unsubscribe anytime.